Prognostic Value of Systemic Inflammatory Response Markers in Patients with Intrahepatic Cholangiocarcinoma
Chenyue Zhang,Haiyong Wang,Zhouyu Ning,Litao Xu,Liping Zhuang,Peng Wang,Zhiqiang Meng
2016-01-01
Abstract:Inflammation is a key feature of cancer, and systemic inflammatory responses (SIRs) have been associated with poor prognosis in patients with various types of cancers. However, studies concerning the role of SIR markers in intrahepatic cholangiocarcinoma (ICC) are relatively limited. Therefore, in the present study, we analyzed the prognostic value of SIR markers in ICC patients. A total of 187 patients with ICC were retrospectively recruited from January 2011 to August 2015 at the Fudan University Shanghai Cancer Center. The association of SIR markers including white blood cell (WBC) count; absolute neutrophil, lymphocyte, and monocyte counts; platelet count, neutrophil: lymphocyte ratio (NLR), platelet: lymphocyte ratio (PLR), and lymphocyte: monocyte ratio (LMR) with overall survival (OS) were determined by Kaplan-Meier analysis and multivariate Cox proportional hazards regression model. Results revealed that high WBC, neutrophil, monocyte, and platelet counts and high NLR, PLR, and a low LMR were significantly correlated with decreased OS. Multivariate analysis demonstrated that WBC count (hazard ratio [HR]=1.932, 95% confidence interval [CI]: 1.376-2.711; P<0.001), neutrophil count (HR=1.755, 95% CI: 1.258-2.448; P=0.001), platelet count (HR=1.483, 95% CI: 1.069-2.057, P=0.018), monocyte count (HR=1.398, 95% CI: 1.008-1.939, P=0.045), NLR (HR=1.700, 95% CI: 1.222-2.366, P=0.002), PLR (HR=1.390, 95% CI: 1.001-1.930, P=0.049), and LMR (HR=0.670, 95% CI: 0.483-0.931, P=0.017) were independently associated with OS. These findings indicated that SIR markers are independent prognostic factors that might be useful for individual risk assessment in patients with ICC.